Review of the current published evidence for single-dose HPV vaccination
The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine. The review also aims to identify gaps that remain in determining whether a single dose could be sufficiently protective to have a major impact against HPV infection and its sequelae, within the context of immunization programs. See also the companion resources:
- General summary (five pages)
- Technical synthesis (30 pages), of immunogenicity, efficacy, and effectiveness, forthcoming evidence, and areas for future research.
Visit the Single-Dose HPV Vaccine Evaluation Consortium page for additional resources.
Publication date: May 2022